Dideoxycytidine ( Ro 24-2027 ) A Randomized, Open-Label, Comparative Study of Dideoxycytidine ( ddC ) Versus Zidovudine ( AZT ) in Patients With AIDS or Advanced ARC Who Have Received Long-Term AZT Therapy.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00000678
Recruitment Status : Completed
First Posted : August 31, 2001
Last Update Posted : March 14, 2011
Hoffmann-La Roche
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID)